Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
New Israeli Technology to Assist in Patients’ Pain Management
Error: Contact form not found.
by JNS.org
An illustration of the pain management technology developed by the Israeli company Medasense Biometrics. Photo: Facebook.
JNS.org – New Israeli technology will help assess and monitor the pain levels of anesthetized patients and enable pain relief medication to be administered more effectively during surgical procedures.
The system analyzes a patient’s physiological responses during an operation and indicates the level of pain being experienced, while allowing patients under anesthesia to “communicate” with doctors and receive appropriate medication.
The technology is the brainchild of the Israeli company Medasense Biometrics. It has been on the market in Europe since early 2017 and recently received approval from the Israeli Health Ministry.
The system will be introduced to the Israeli market next week during the annual international conference hosted by the Israeli Society of Anesthesiologists.
“There are no clinical tools today that enable the assessment and monitoring of pain levels in an objective manner,” said Medasense founder and CEO Galit Zuckerman.
“The consensus today is that objective pain assessment will revolutionize the way a patient’s pain is treated because on the one hand it will allow for pain reduction in patients, and on the other hand it will minimize side effects caused by excessive use of pain medication,” she said.
